Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
NurExone Biologic Inc a pioneering biopharmaceutical company developing regenerative medicine therapies is pleased to announce that the Japan
Ascentage Pharma a global biopharmaceutical company engaged in developing novel therapies for cancer chronic hepatitis B and agerelated diseases announced today that the Center for Drug Evaluation
Hudson Therapeutics announced that Shaperon an innovative biopharmaceutical company specializing in immune therapeutics has signed a Memorandum of Understanding with DongA ST KOSPI CEO MinYoung Kim for the development of nanobodybased new drugs
J INTS BIO provided an update of its ongoing Phase clinical study of JINA a th generation EGFRTKI for NSCLC treatment during the rd of June poster session of the American Society of Clinical Oncology
GC Biopharma and Novel Pharma have announced that the US FDA has granted Fast Track Designation for their jointly developed MPSIIIA treatment GCA This designation follows the FDAs clearance of the investigational new drug application for GCA last mon...
MLB a biomedical company announced that the US Food and Drug Administration has approved IND application for TML an novel drug to treat Alzheimers disease
Nagase Viita Co Ltd a member of the NAGASE Group has launched a new product brand SOLBIOTETM featuring our saccharidebased pharmaceutical excipients of highpurity and lowendotoxin
Theralase Technologies Inc is a clinical stage pharmaceutical company that is dedicated to the research and development of light andor radiation activated small molecules for the safe and effective destruction of various cancers bacteria and viruses
HUTCHMED China Limited today announces that it has initiated Phase I clinical trial of its menin inhibitor HMPL in patients with hematological malignancies in China The first patient received their first
Scilex Holding Company an innovative revenuegenerating company focused on acquiring developing
